These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9254630)

  • 1. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
    Wiese A; Brandenburg K; Lindner B; Schromm AB; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10301-10. PubMed ID: 9254629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the glycostructure of amphiphilic membrane components on the function of the outer membrane of Gram-negative bacteria as a matrix for incorporated channels and a target for antimicrobial peptides or proteins.
    Gutsmann T; Seydel U
    Eur J Cell Biol; 2010 Jan; 89(1):11-23. PubMed ID: 19939497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
    Wiese A; Gutsmann T; Seydel U
    J Endotoxin Res; 2003; 9(2):67-84. PubMed ID: 12803879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures.
    Domingues MM; Bianconi ML; Barbosa LR; Santiago PS; Tabak M; Castanho MA; Itri R; Santos NC
    Biochim Biophys Acta; 2013 Nov; 1828(11):2419-27. PubMed ID: 23792068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
    Gutsmann T; Hagge SO; David A; Roes S; Böhling A; Hammer MU; Seydel U
    J Endotoxin Res; 2005; 11(3):167-73. PubMed ID: 15949145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
    Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
    Wu M; Maier E; Benz R; Hancock RE
    Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bactericidal/permeability-increasing protein in experimental otitis media with effusion in rats: a new therapy for mucosal infections.
    Nell MJ; Grote JJ
    J Lab Clin Med; 2001 Apr; 137(4):303-9. PubMed ID: 11283526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
    Domingues MM; Santos NC; Castanho MA
    Curr Protein Pept Sci; 2012 Nov; 13(7):611-9. PubMed ID: 23116442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes.
    Gutsmann T; Haberer N; Carroll SF; Seydel U; Wiese A
    Biol Chem; 2001 Mar; 382(3):425-34. PubMed ID: 11347890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
    Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
    Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
    Domingues MM; Silva PM; Franquelim HG; Carvalho FA; Castanho MA; Santos NC
    Nanomedicine; 2014 Apr; 10(3):543-51. PubMed ID: 24262996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.